• Home
    • Documents
    • Teva Pharmaceutical Industries Ltd. et al: Statement of Charges

    Teva Pharmaceutical Industries Ltd. et al: Statement of Charges

    Statement of Charges and Notice of Hearing regarding the “false and misleading marketing” of opiod products in the matter of Teva Pharmaceutical Industries Ltd., of Israel; Teva Pharmaceuticals USA Inc., of Pennsylvania; Cephalon Inc., of Delaware; Watson Laboratories Inc., of Nevada; Actavis Pharma Inc., of Delaware; Actavis LLC, of Delaware; Actavis Elizabeth LLC, of Delaware; Allergan Plc, of Ireland, and Allergan Finance LLC, of Nevada, before the New York State Department of Financial Services.


  • 30
    August 17, 2020
    Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc., Cephalon Inc., Watson Laboratories Inc., Actavis Pharma Inc., Actavis LLC, Actavis Elizabeth LLC, Allergan Plc, Allergan Finance LLC
    New York State Department of Financial Services
    Xx Xx Xx
    Regulatory
    Fraud